Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms17050627 http://scihub22266oqcxt.onion/10.3390/ijms17050627 C4881453!4881453!27128908     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Mol+Sci 2016 ; 17 (5): ä Nephropedia Template TP {{tp|p=27128908|t=2016. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies |pdf=|usr=}}{{27128908}} gab.com Text New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=27128908 #FOAvip The effective and efficient management of cancer patients relies upon early diagnosis and/or the monitoring of treatment, something that is often difficult to achieve using standard tissue biopsy techniques. Biological fluids such as blood hold great possibilities as a source of non-invasive cancer biomarkers that can act as surrogate markers to biopsy-based sampling. The non-invasive nature of these ?liquid biopsies? ultimately means that cancer detection may be earlier and that the ability to monitor disease progression and/or treatment response represents a paradigm shift in the treatment of cancer patients. Below, we review one of the most promising classes of circulating cancer biomarkers: microRNAs (miRNAs). In particular, we will consider their history, the controversy surrounding their origin and biology, and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. Twit Text FOAVip New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=27128908 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27128908 #FOAvip English Wikipedia <ref>{{Cite pmid|27128908}}</ref> New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies #MMPMID27128908 Larrea E; Sole C; Manterola L; Goicoechea I; Armesto M; Arestin M; Caffarel MM; Araujo AM; Araiz M; Fernandez-Mercado M; Lawrie CH Int J Mol Sci 2016[May]; 17 (5): ä PMID27128908show ga The effective and efficient management of cancer patients relies upon early diagnosis and/or the monitoring of treatment, something that is often difficult to achieve using standard tissue biopsy techniques. Biological fluids such as blood hold great possibilities as a source of non-invasive cancer biomarkers that can act as surrogate markers to biopsy-based sampling. The non-invasive nature of these ?liquid biopsies? ultimately means that cancer detection may be earlier and that the ability to monitor disease progression and/or treatment response represents a paradigm shift in the treatment of cancer patients. Below, we review one of the most promising classes of circulating cancer biomarkers: microRNAs (miRNAs). In particular, we will consider their history, the controversy surrounding their origin and biology, and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. äNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsi(epmc).pdf DeepDyve Pubget Overpricing